From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance ...

The Indian Institute of Technology-Madras announced a breakthrough artificial intelligence framework that can rapidly generate drug-like molecules that are easier to synthesise in real-world ...

Until recently, he also served as Head of the Center for Computational Natural Sciences and Bioinformatics (CCNSB). His ...

By combining mass spectrometry imaging with an automated analysis tool, researchers from Hebrew University have developed a ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and ...

The integration of single-cell RNA sequencing (scRNA-seq) with AI has become a cornerstone for deciphering tumor heterogeneity. For instance, in pancreatic ductal adenocarcinoma (PDAC), spatial ...

Pharmaron entered a Share Purchase Agreement to acquire 82.54% equity interest of Biortus to enhance structure-based drug discovery & protein science.

ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical ...

Explore Cerebras’s new Oklahoma data center, the fastest AI facility globally, featuring 44 exaflops of power and innovative technologies.

Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...